Along his diverse career path, Dr. Puech d'Alissac has held positions of high responsibility in Europe, Africa, Asia and North America. His extensive knowledge and proven track record enable him to bring a broad strategic vision and considerable operational capabilities to Sintetica…

Sintetica's other production site in Couvet, which has been completely renovated thanks to considerable investments in recent years, has also been approved by the US Federal Drug Administration (FDA)…

Lidocaine hydrochloride is a short-acting amide-type local anesthetic with a rapid onset and short duration of action and contains no preservatives.

Sintetica, a Swiss pharmaceutical company headquartered in Mendrisio and specialized in the production of injectable medicines in the field of pain therapy…

Harrow Announces U.S. FDA Approval of IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia…